Menu

Neurons That Recognize Tone Identified

The cells are crucial to detecting emphasis, sarcasm, and uptalk in human conversation.

Aug 28, 2017
Shawna Williams

Researchers identified neurons that help discern changes in relative pitch.CARLA SCHAFFER/AAASResearchers at the University of California, San Francisco, have identified specialized brain cells that detect changes in the pitch of speech, they reported last week (August 24) in Science. Such changes are crucial to understanding emphasis in spoken speech, determining question from statement, and distinguishing between different words in tonal languages such as Chinese.

As coauthor and neurosurgeon Edward Chang explains to Wired, “These differences are all really important, because they change the meaning of the words without changing the words themselves.”

For their study, Chang and colleagues recruited 10 people with epilepsy who already have electrodes implanted in their brains to detect where seizures originate. The researchers used the electrodes to track brain activity as the subjects listened to sentences read by three speakers, with different words emphasized. They found an area of the brain in the auditory cortex within the superior temporal gyrus that responds just to changes in the pitch of speech, independently of the consonant and vowel sounds it contains.

“Processing sound is one of the most complex jobs that we ask our brain to do,” Nina Kraus, a neurobiologist who runs the Auditory Neuroscience Laboratory at Northwestern University, tells NPR.

She says the skill enabled by the newly identified brain region—recognizing changes in intonation—is often impaired in people on the autism spectrum. “A typically developing child will process those pitch contours very precisely,” she says. “But some kids on the autism spectrum don’t. They understand the words you are saying, but they are not understanding how you mean it.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.